Literature DB >> 7514601

Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase.

B Dong1, L Xu, A Zhou, B A Hassel, X Lee, P F Torrence, R H Silverman.   

Abstract

2-5A-dependent RNase (RNase L), a unique endoribonuclease that requires 5'-phosphorylated 2',5'-linked oligoadenylates (2-5A), functions in the molecular mechanism of interferon action. Because this enzyme is present at very low levels in nature, characterization and analysis have been limited. The molecular cloning of human, 2-5A-dependent RNase cDNA has facilitated its expression to high levels in insect cells by infecting with recombinant baculovirus. To determine the properties of the enzyme in the absence of other proteins, the recombinant 2-5A-dependent RNase was purified to homogeneity. The purified enzyme migrated as a monomer upon gel filtration in the absence of activator and showed highly specific, 2-5A-dependent RNase activity. The precise activator requirements were determined by stimulating the purified enzyme with a variety of 2',5'-linked oligonucleotides. The activated enzyme was capable of cleaving poly(rU) and, to a lesser extent, poly(rA), to sets of discrete products ranging from between 4 and 22 nucleotides in length. Reduced rates of 2-5A-dependent RNA cleavage were observed even after removal of ATP and chelation of divalent cations. However, optimal RNA cleavage rates required the presence of either manganese or magnesium and ATP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514601

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Basis for regulated RNA cleavage by functional analysis of RNase L and Ire1p.

Authors:  B Dong; M Niwa; P Walter; R H Silverman
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

2.  Inhibition of RNase L and RNA-dependent protein kinase (PKR) by sunitinib impairs antiviral innate immunity.

Authors:  Babal Kant Jha; Irina Polyakova; Patricia Kessler; Beihua Dong; Benjamin Dickerman; Ganes C Sen; Robert H Silverman
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

Review 3.  New insights into the role of RNase L in innate immunity.

Authors:  Arindam Chakrabarti; Babal Kant Jha; Robert H Silverman
Journal:  J Interferon Cytokine Res       Date:  2010-12-29       Impact factor: 2.607

4.  A mammalian 2-5A system functions as an antiviral pathway in transgenic plants.

Authors:  A Mitra; D W Higgins; W G Langenberg; H Nie; D N Sengupta; R H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

5.  Structure of the dual enzyme Ire1 reveals the basis for catalysis and regulation in nonconventional RNA splicing.

Authors:  Kenneth P K Lee; Madhusudan Dey; Dante Neculai; Chune Cao; Thomas E Dever; Frank Sicheri
Journal:  Cell       Date:  2008-01-11       Impact factor: 41.582

Review 6.  A scientific journey through the 2-5A/RNase L system.

Authors:  Robert H Silverman
Journal:  Cytokine Growth Factor Rev       Date:  2007-07-27       Impact factor: 7.638

7.  Kinetic Differences and Synergistic Antiviral Effects Between Type I and Type III Interferon Signaling Indicate Pathway Independence.

Authors:  Emily A Voigt; John Yin
Journal:  J Interferon Cytokine Res       Date:  2015-05-04       Impact factor: 2.607

8.  RNase L triggers autophagy in response to viral infections.

Authors:  Arindam Chakrabarti; Prabar Kumar Ghosh; Shuvojit Banerjee; Christina Gaughan; Robert H Silverman
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

9.  Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L.

Authors:  A Zhou; J Paranjape; T L Brown; H Nie; S Naik; B Dong; A Chang; B Trapp; R Fairchild; C Colmenares; R H Silverman
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

10.  Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.

Authors:  Nobutada Tanaka; Masayuki Nakanishi; Yoshio Kusakabe; Yoshikuni Goto; Yukio Kitade; Kazuo T Nakamura
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.